University of Michigan, Medical School

Ann Arbor, Michigan 48109-5624

3 studies enrolling now · 28 studies all time

What they study most

Acute Alcoholic Hepatitis, Acute Liver Failure, Acute Liver Injury, Drug Induced, Acute on Chronic Liver Failure (ACLF), Adherence, Medication, Advanced or Metastatic Solid Tumors, Anaplastic Thyroid Cancer, Anticoagulants and Bleeding Disorders, Atrial Fibrillation, Atrial Flutter, Bleeding, Breast Cancer

Studies at this site

• Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A — Recruiting now
• Intern Health Study — Enrolling by invitation
• Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation — Enrolling by invitation
• miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial — Completed
• Pleural Manometry for the Characterization of Spontaneous and Tension Pneumothorax — Completed
• Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol — Completed
• Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection — Running, not enrolling
• PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy — Completed
• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) — Stopped early
• Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR) — Completed
• A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer — Completed
• Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML — Stopped early
• A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors — Completed
• Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients — Completed
• Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures. — Stopped early
• Cognitive Training for the Prevention of Postoperative Delirium — Completed
• Ongoing Diabetes Self-Management Support in Church-Based Settings — Completed
• Effects of Provider Commitments to Choose Wisely — Completed
• Endogenous Opioid Activity and Affective State in Insulin Resistant Women — Completed
• A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool — Completed
• Neurohormonal & Behavioral Correlates of Obesity and Weight Loss — Completed
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) — Completed
• Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis — Completed
• Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation — Stopped early
• Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis — Completed
• Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung — Completed